Keywords: cytokinetics, abandons, ispinesib, ph, ii, usa-based, small-molecule

Cytokinetics abandons ispinesib at Ph II

Article | 03 April 2006

Print This

USA-based small-molecule drugmaker Cytokinetics says that its cancer drug ispinesib did not meet the necessary criteria to proceed to the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in